An exploratory study on the molecular biological characteristics of lower extremity atherosclerosis

Not Applicable

Recruiting

• Conditions: ower extremity artery disease; Lower extremity artery disease

• Registration Number: JPRN-jRCTs052230062
• Lead Sponsor: Otake Hiromasa

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-07-03
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

(1) LEAD patients scheduled to undergo elective EVT for femoropopliteal or below-knee ar
tery lesions
(2) Patients whose lesions to be treated were determined to be non-calcified lesions
(3) Patients with lesions >4 mm in reference vessel diameter on preoperative angiography or CT examination
(4) Patients who are 18 years of age or older at the time of informed consent
(5) Patients who can understand the content of the treatment and the purpose of the research, and
who are able to obtain written informed consent of their own free will.

Exclusion Criteria

(1) Patients with acute limb ischemia or acutethrombosis
(2) In-stent stenosis or occlusive lesion
(3) Rutherford Category 6, or Critical limb ischemia suspected of widespread infection
(4) Patients who find it difficult to continue antiplatelet therapy (such as patients planning surgery that requires withdrawal of antiplatelet agents within one month)
(5) Patients who are pregnant/lactating or may be pregnant
(6) Other patients who are judged inappropriate by the principle investigator or subinvestigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified